Orbimed Advisors LLC Catalyst Biosciences, Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.51 - $1.0 $881,995 - $1.73 Million	-1,729,402 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $893,800 - $4.09 Million	-982,198 Reduced 36.22%	1,729,402 $1.58 Million
Q3 2021 Nov 15, 2021	BUY	$3.78 - $5.18 $2.24 Million - $3.07 Million	593,000 Added 27.99%	2,711,600 $11.1 Million
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $10.4 Million - $15.1 Million	2,118,600 New	2,118,600 $10.7 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.